-
2
-
-
23244438005
-
The elevated 10-Year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice
-
DOI 10.1093/jnci/dji187
-
Khan MJ, Castle PE, Lorincz AT, et al. The elevated 10-year risk of cervical precancer and cancer in momen with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst. 2005;97:1072-1079. (Pubitemid 41417924)
-
(2005)
Journal of the National Cancer Institute
, vol.97
, Issue.14
, pp. 1072-1079
-
-
Khan, M.J.1
Castle, P.E.2
Lorincz, A.T.3
Wacholder, S.4
Sherman, M.S.5
Scott, D.R.6
Rush, B.R.7
Glass, A.G.8
Schiffman, M.9
-
3
-
-
34250818010
-
Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: A meta-analysis update
-
DOI 10.1002/ijc.22527
-
Smith JS, Lindsay L, Hoots B, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer. 2007;121:621-632. (Pubitemid 46986496)
-
(2007)
International Journal of Cancer
, vol.121
, Issue.3
, pp. 621-632
-
-
Smith, J.S.1
Lindsay, L.2
Hoots, B.3
Keys, J.4
Franceschi, S.5
Winer, R.6
Clifford, G.M.7
-
4
-
-
0033695944
-
The significance of tumor size in clinical stage IB cervical cancer: Can a cut-off figure be determined?
-
Nakanishi T, Ishikawa H, Nawa A, et al. The significance of tumor size in clinical stage IB cervical cancer: can a cut-off figure be determined? Int J Gynecol Cancer. 2000;10:397-401.
-
(2000)
Int J Gynecol Cancer
, vol.10
, pp. 397-401
-
-
Nakanishi, T.1
Ishikawa, H.2
Nawa, A.3
-
5
-
-
0024450296
-
Identification of prognostic factors and risk groups in patients found to have nodal metastasis at the time of radical hysterectomy for early-stage squamous carcinoma of the cervix
-
DOI 10.1016/0090-8258(89)90029-2
-
Alvarez RD, Soong SJ, Kinney WK, et al. Identification of prognostic factors and risk groups in patients found to have nodal metastasis at the time of radical hysterectomy for early-stage squamous carcinoma of the cervix. Gynecol Oncol. 1989;35:130-135. (Pubitemid 19268543)
-
(1989)
Gynecologic Oncology
, vol.35
, Issue.2
, pp. 130-135
-
-
Alvarez, R.D.1
Soong, S.-J.2
Kinney, W.K.3
Reid, G.C.4
Schray, M.F.5
Podratz, K.C.6
Morley, G.W.7
Shingleton, H.M.8
-
6
-
-
0024828963
-
A prospective surgical pathological study of stage I squamous carcinoma of the cervix: a Gynecologic Oncology Group study
-
DOI 10.1016/0090-8258(89)90070-X
-
Delgado G, Bundy BN, Fowler WC, et al. A prospective surgical pathological study of stage I squamous carcinoma of the cervix: a Gynecologic Oncology Group Study. Gynecol Oncol. 1989;35:314-320. (Pubitemid 20025893)
-
(1989)
Gynecologic Oncology
, vol.35
, Issue.3
, pp. 314-320
-
-
Delgado, G.1
Bundy, B.N.2
Fowler Jr., W.C.3
Stehman, F.B.4
Sevin, B.5
Creasman, W.T.6
Major, F.7
DiSaia, P.8
Zaino, R.9
-
7
-
-
0018578536
-
Classification and grading of invasive squamous cell carcinoma of the uterine cervix
-
Stendahl U, Willen H, Willen R. Classification and grading of invasive squamous cell carcinoma of the uterine cervix. Acta Radiol Oncol Radiat Phys Biol. 1979;18:481-496.
-
(1979)
Acta Radiol Oncol Radiat Phys Biol
, vol.18
, pp. 481-496
-
-
Stendahl, U.1
Willen, H.2
Willen, R.3
-
8
-
-
0032770596
-
Tumor size, depth of invasion, and grading of the invasive tumor front are the main prognostic factors in early squamous cell cervical carcinoma
-
DOI 10.1006/gyno.1999.5420
-
Kristensen GB, Abeler VM, Risberg B, et al. Tumor size, depth of invasion, and grading of the invasive tumor front are the main prognostic factors in early squamous cell cervical carcinoma. Gynecol Oncol. 1999;74:245-251. (Pubitemid 29377220)
-
(1999)
Gynecologic Oncology
, vol.74
, Issue.2
, pp. 245-251
-
-
Kristensen, G.B.1
Abeler, V.M.2
Risberg, B.3
Trope, C.4
Bryne, M.5
-
9
-
-
0024376173
-
Ras Oncogenes in human cancer: A review
-
Bos JL. Ras oncogenes in human cancer: a review. Cancer Res. 1989;49:4682-4689. (Pubitemid 19213607)
-
(1989)
Cancer Research
, vol.49
, Issue.17
, pp. 4682-4689
-
-
Bos, J.L.1
-
10
-
-
0029127661
-
Frequent ras gene mutations in squamous cell cervical cancer
-
Wong YF, Chung TKH, Cheung TH, et al. Frequent ras gene mutations in squamous cell cervical cancer. Cancer Lett. 1995;95:29-32.
-
(1995)
Cancer Lett
, vol.95
, pp. 29-32
-
-
Wong, Y.F.1
Chung, T.K.H.2
Cheung, T.H.3
-
11
-
-
0032878882
-
Differences in K-ras codon 12 mutation frequency between 'high-risk' and 'low-risk' HPV-infected samples
-
DOI 10.1006/gyno.1999.5528
-
Golijow CD, Mourón SA, Gómez MA, et al. Differences in K-ras codon 12 mutation frequency between "high-risk" and "low-risk" HPV-infected samples. Gynecol Oncol. 1999;75:108-112. (Pubitemid 29477811)
-
(1999)
Gynecologic Oncology
, vol.75
, Issue.1
, pp. 108-112
-
-
Golijow, C.D.1
Mouron, S.A.2
Gomez, M.A.3
Dulout, F.N.4
-
12
-
-
0031858459
-
Detection of HPV and ras gene mutations in cervical smears from female genital lesions
-
Dokianakis DN, Sourvinos G, Sakkas S, et al. Detection of HPV and ras gene mutations in cervical smears from female genital lesions. Oncol Rep. 1998;5:1195-1198. (Pubitemid 28372586)
-
(1998)
Oncology Reports
, vol.5
, Issue.5
, pp. 1195-1198
-
-
Dokianakis, D.N.1
Sourvinos, G.2
Sakkas, S.3
Athanasiadou, E.4
Spandidos, D.A.5
-
13
-
-
0034837831
-
'Low-risk' and 'high-risk' HPV-infection and K-ras gene point mutations in human cervical cancer: A study of 31 cases
-
Stenzel A, Semczuk A, Rózycska K, et al. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases. Pathol Res Pract. 2001;197:597-603. (Pubitemid 32834399)
-
(2001)
Pathology Research and Practice
, vol.197
, Issue.9
, pp. 597-603
-
-
Stenzel, A.1
Semczuk, A.2
Roynska, K.3
Jakowicki, J.4
Wojcierowski, J.5
-
14
-
-
0141888073
-
Absence of point mutation in codons 12 and 13 of K-RAS oncogene in HPV-associated high grade dysplasia and squamous cell cervical carcinoma
-
DOI 10.1016/S0301-2115(03)00205-7
-
Pochylski T, Kwavniewska A. Absence of point mutation in codons 12 and 13 of K-RAS oncogene in HPV-associated high grade dysplasia and squamous cell cervical carcinoma. Eur J Obstet Gynecol Reprod Biol. 2003;111:68-73. (Pubitemid 37235950)
-
(2003)
European Journal of Obstetrics Gynecology and Reproductive Biology
, vol.111
, Issue.1
, pp. 68-73
-
-
Pochylski, T.1
Kwasniewska, A.2
-
15
-
-
1342279497
-
Transcriptional activation of H- and N-ras oncogenes in human cervical cancer
-
DOI 10.1016/j.ygyno.2003.11.040
-
Mammas IN, Zafiropoulos A, Koumantakis E, et al. Transcriptional activation of H- and N-ras oncogenes in human cervical cancer. Gynecol Oncol. 2004;92:941-948. (Pubitemid 38251400)
-
(2004)
Gynecologic Oncology
, vol.92
, Issue.3
, pp. 941-948
-
-
Mammas, I.N.1
Zafiropoulos, A.2
Koumantakis, E.3
Sifakis, S.4
Spandidos, D.A.5
-
16
-
-
32644461203
-
Consistent absence of BRAF mutations in cervical and endometrial cancer despite KRAS mutation status
-
DOI 10.1016/j.ygyno.2005.09.029, PII S0090825805008255
-
Pappa KI, Choleza M, Markaki S, et al. Consistent absence of BRAF mutations in cervical and endometrial cancer despite KRAS mutation status. Gynecol Oncol. 2006;100:596-600. (Pubitemid 43246877)
-
(2006)
Gynecologic Oncology
, vol.100
, Issue.3
, pp. 596-600
-
-
Pappa, K.I.1
Choleza, M.2
Markaki, S.3
Giannikaki, E.4
Kyroudi, A.5
Vlachos, G.6
Voulgaris, Z.7
Anagnou, N.P.8
-
17
-
-
0030800498
-
K-ras mutations in patients with early colorectal cancers
-
Andreyev HJ, Tilsed JV, Cunningham D, et al. K-ras mutations in patients with early colorectal cancers. Gut. 1997;41:323-329. (Pubitemid 27428190)
-
(1997)
Gut
, vol.41
, Issue.3
, pp. 323-329
-
-
Andreyev, H.J.N.1
Tilsed, J.V.T.2
Cunningham, D.3
Sampson, S.A.4
Norman, A.R.5
Schneider, H.J.6
Clarke, P.A.7
-
18
-
-
0032424640
-
K-ras gene point mutations in human endometrial carcinomas: Correlation with clinicopathological features and patients' outcome
-
DOI 10.1007/s004320050234
-
Semczuk A, Berbeć H, Kostuch M, et al. K-ras gene point mutations in human endometrial carcinomas: correlation with clinicopathological features and patients' outcome. J Cancer Res Clin Oncol. 1998;124:695-700. (Pubitemid 29003303)
-
(1998)
Journal of Cancer Research and Clinical Oncology
, vol.124
, Issue.12
, pp. 695-700
-
-
Semczuk, A.1
Berbec, H.2
Kostuch, M.3
Cybulski, M.4
Wojcierowski, J.5
Baranowski, W.6
-
19
-
-
67651241726
-
Prognostic value of KRAS mutations and Ki-67 expression in stage I lung adenocarcinomas
-
Woo T, Okudela K, Yazawa T, et al. Prognostic value of KRAS mutations and Ki-67 expression in stage I lung adenocarcinomas. Lung Cancer. 2009;65:355-362.
-
(2009)
Lung Cancer
, vol.65
, pp. 355-362
-
-
Woo, T.1
Okudela, K.2
Yazawa, T.3
-
20
-
-
61449154484
-
KRAS mutation and sensitivity to epidermal growth factor receptor inhibitors in colorectal cancer: Practical application of patient selection
-
Jimeno A, Messersmith WA, Hirsch FR, et al. KRAS mutation and sensitivity to epidermal growth factor receptor inhibitors in colorectal cancer: Practical application of patient selection. J Clin Oncol. 2009;27:1130-1136.
-
(2009)
J Clin Oncol
, vol.27
, pp. 1130-1136
-
-
Jimeno, A.1
Messersmith, W.A.2
Hirsch, F.R.3
-
21
-
-
68749119351
-
KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer
-
Loupakis F, Ruzzo A, Cremolini C, et al. KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer. Br J Cancer. 2009;101:715-721.
-
(2009)
Br J Cancer
, vol.101
, pp. 715-721
-
-
Loupakis, F.1
Ruzzo, A.2
Cremolini, C.3
-
22
-
-
45849120146
-
RAS signaling in colorectal carcinomas through alterations of RAS, RAF, NF1, and/or RASSF1A
-
DOI 10.1593/neo.08312
-
Ahlquist T, Bottillo I, Danielsen SA, et al. RAS signaling in colorectal carcinomas through alterations of RAS, RAF, NF1, and/or RASSF1A. Neoplasia. 2008;10:680-686. (Pubitemid 351883884)
-
(2008)
Neoplasia
, vol.10
, Issue.7
, pp. 680-686
-
-
Ahlquist, T.1
Bottillo, I.2
Danielsen, S.A.3
Meling, G.I.4
Rognum, T.O.5
Lind, G.E.6
Dallapiccola, B.7
Lothe, R.A.8
-
23
-
-
54949085398
-
K-ras mutations and benefit from Cetuximab in advanced colorectal cancer
-
Karapetis CS, Khambata-Ford S, Jonker DJ, et al. K-ras mutations and benefit from Cetuximab in advanced colorectal cancer. N Engl J Med. 2009;359:1757-1765.
-
(2009)
N Engl J Med
, vol.359
, pp. 1757-1765
-
-
Karapetis, C.S.1
Khambata-Ford, S.2
Jonker, D.J.3
-
24
-
-
0028206113
-
Mutations that abolish the ability of Ha-Ras to associate with Raf-1
-
Shirouzu M, Koide H, Fujita-Yoshigaki J, et al. Mutations that abolish the ability of Ha-Ras to associate with Raf-1. Oncogene. 1994;9:2153-2157. (Pubitemid 24228663)
-
(1994)
Oncogene
, vol.9
, Issue.8
, pp. 2153-2157
-
-
Shirouzu, M.1
Koide, H.2
Fujita-Yoshigaki, J.3
Oshio, H.4
Toyama, Y.5
Yamasaki, K.6
Fuhrman, S.A.7
Villafranca, E.8
Kaziro, Y.9
Yokoyama, S.10
-
25
-
-
0029147166
-
Different structural requirements within the switch II region of the Ras protein for interactions with specific downstream targets
-
Moodie SA, Paris M, Villafranca E, et al. Different structural requirements within the switch II region of the Ras protein for interactions with specific downstream targets. Oncogene. 1995;11:447-454.
-
(1995)
Oncogene
, vol.11
, pp. 447-454
-
-
Moodie, S.A.1
Paris, M.2
Villafranca, E.3
|